Clinical Response to Seribantumab, an Anti–Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an <i>NRG1</i> FusionSubotheni Thavaneswaran, David M. Thomas, Ray Asghari et al.|JCO Precision Oncology|2022Cited by 8